Luo, D.; Xu, X.; Iqbal, M.Z.; Zhao, Q.; Zhao, R.; Farheen, J.; Zhang, Q.; Zhang, P.; Kong, X.
siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. Pharmaceutics 2021, 13, 1428.
https://doi.org/10.3390/pharmaceutics13091428
AMA Style
Luo D, Xu X, Iqbal MZ, Zhao Q, Zhao R, Farheen J, Zhang Q, Zhang P, Kong X.
siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. Pharmaceutics. 2021; 13(9):1428.
https://doi.org/10.3390/pharmaceutics13091428
Chicago/Turabian Style
Luo, Dandan, Xiaochun Xu, M. Zubair Iqbal, Qingwei Zhao, Ruibo Zhao, Jabeen Farheen, Quan Zhang, Peiliang Zhang, and Xiangdong Kong.
2021. "siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy" Pharmaceutics 13, no. 9: 1428.
https://doi.org/10.3390/pharmaceutics13091428
APA Style
Luo, D., Xu, X., Iqbal, M. Z., Zhao, Q., Zhao, R., Farheen, J., Zhang, Q., Zhang, P., & Kong, X.
(2021). siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. Pharmaceutics, 13(9), 1428.
https://doi.org/10.3390/pharmaceutics13091428